Our findings are also consistent in part with a previous study of NODDI and CSF biomarkers of AD pathology (which do not provide anatomic information), which found that alterations in Aβ alone were not associated with lower NDI but alterations in both p‐tau and Aβ in combination were.22 Here, MAPT is linked to Alzheimer disease.